Coherent Market Insights Named Strategic Partner for Pharmaconex 2026

Cairo, Egypt, September 2026: Coherent Market Insights (CMI) joins as Strategic Partner for Pharmaconex 2026, organized by Informa Egypt LLC. The exhibition will take place from September 1–3, 2026, at the Egypt International Exhibition Centre in Cairo. The event brings together pharmaceutical manufacturers, API producers and suppliers, Contract Development and Manufacturing Organizations (CDMOs), healthcare innovators, distributors, and investors from across the region and beyond.

CMI’s role goes beyond a logo on a banner. Its contribution involves a dedicated research and sharing an Executive Market Intelligence Report which is designed specifically for the pharmaceutical manufacturing and API space, alongside a coordinated media and outreach effort intended to extend the exhibition's reach.

An Industry Recalibrating Its Supply Chains

The timing of this partnership tracks a period of real structural change in global pharmaceutical manufacturing. Supply chain diversification, regulatory tightening, and a renewed push toward API localization are reshaping where and how production happens. That shift promptes manufacturers and CDMOs alike to reassess long-standing sourcing decisions. Investment activity is following that same shift, with capital increasingly directed toward regions and facilities positioned to absorb this realignment.

CMI's engagement in this event was structured not as a general sponsorship, but as a knowledge layer built specifically around the questions manufacturers, suppliers, and investors are currently trying to answer.

CMI's Contribution: Research, Reach, and Media Infrastructure

As part of this partnership, CMI offers an Executive Market Intelligence Report ‘Global Pharmaceutical Manufacturing & API Market – Trends, Investment Outlook & Forecast 2026–2033’. The report covers the global manufacturing landscape, API market trends, supply chain transformation and localization strategies, regulatory developments, competitive positioning, and forward-looking investment opportunities. This is assembled to function as a working reference for exhibitors and visitors navigating the show.

CMI as Strategic Partner: The Rationale

For CMI, the engagement reflects a broader pattern of anchoring its research and advisory capabilities across major industry platforms not just observing sector shifts from the outside, but embedding data-driven perspective directly into the events where deals, partnerships, and sourcing decisions are being shaped in real time.

Leadership Perspective

"The pharmaceutical industry is entering a transformative phase driven by evolving manufacturing strategies, supply chain shifts, innovation, and emerging market opportunities," said Raj Shah, CEO and Founder, CMI. "Through our partnership with Pharmaconex 2026, CMI aims to provide stakeholders with actionable intelligence and strategic perspectives that support informed decision-making and sustainable growth."

Event Details at a Glance

About Pharmaconex 2026

Organized by Informa Egypt LLC, Pharmaconex 2026 is a leading pharmaceutical exhibition connecting manufacturers, API producers and suppliers, CDMOs, healthcare innovators, distributors, and investors across the pharmaceutical value chain, strengthening industry connections across the MENA region and globally.

About Coherent Market Insights

Coherent Market Insights (CMI) is a global market intelligence and consulting firm delivering data-driven insights across multiple industries. Headquartered in India, with a presence in the U.S. and strategic partnerships across the U.K. and Japan, CMI supports clients in over 32 countries with 300+ full-time consultants and a global network of domain experts across 24 countries.

For business inquiries, contact: sales@coherentmarketinsights.com